Jan 6, 2025, 11:11
Akhil Santhosh: Switching 5 FU for docetaxel in the Tp-EXTREME trial
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, posted on X:
“Switching 5 FU for docetaxel in the Tp-EXTREME trial results in similar OS with a better safety profile.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 30, 2025, 13:41
Mar 30, 2025, 13:32
Mar 30, 2025, 12:49
Mar 30, 2025, 12:14
Mar 30, 2025, 11:55